Abstract Background D-psicose 3-epimerase (DPEase) is a potential catalytic enzyme for D-psicose production. D-psicose, also known as D-allulose is a low-calorie sweetener that has garnered considerable attention for healthy alternative sweetener due to its remarkable physicochemical properties. This research focused on an in-depth investigation of the expression of the constructed DPEase gene from Agrobacterium tumefaciens in Escherichia coli for D-psicose synthesis, with a strong emphasis on scalability. Experimentally, this research created the recombinant enzyme, explored the optimization of gene expression systems and protein purification strategies, and then investigated the enzymatic characterization to establish a robust and scalable process for D-psicose production. Additionally, the optimization of D-psicose production using the recombinant DPEase was also studied. Finally, the produced D-psicose syrup was underwent acute toxicity evaluation to provide scientific evidence supporting its safety.Results The optimization of DPEase expression involved the utilization of Mn²⁺ as a cofactor, fine-tuning isopropyl β-D-1-thiogalactopyranoside (IPTG) induction, and controlling induction temperature. The purification process was strategically designed to facilitate industrial-scale operations. A nickel column and an elution buffer containing 200 mM imidazole were employed, resulting in purified DPEase with a remarkable 21.03-fold increase in specific activity compared to the crude extract. The optimum D-psicose conversion conditions of purified DPEase were performed at pH 7.5 and 55°C under Mn²⁺ addition as the cofactor. Kinetic parameters of purified DPEase, Vmax and Km, were determined, demonstrating the high substrate affinity and efficiency of DPEase, which are crucial factors for achieving cost-effective for D-psicose production that was confirmed by binding site of fructose-DPEase-Mn²⁺ structure. Stability studies were conducted to ensure the enzyme's robustness during storage, which the glycerol supplementation and storage at -20°C were identified as effective strategies for maintaining its stability. D-psicose production using purified DPEase was investigated across a range of fructose concentrations, with a focus on optimizing yields for industrial applications. Moreover, the results from acute toxicity study showed no toxicity to rats, supporting the safety of mixed D-fructose-D-psicose syrup produced using recombinant DPEase.Conclusions These findings have direct and practical implications for the industrial-scale production of D-psicose, a valuable rare sugar with a broad range of applications in the food and pharmaceutical industries. Our research advances the understanding of DPEase biocatalysis and offers a roadmap for the successful scale-up production of rare sugars, opening new avenues for their utilization in various industrial processes.
No takes yet. Share an insight, caveat, or question.
Watthanasakphuban et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: